Post-randomized consent

Also known as Zelen's design, this is an experiment design for randomized clinical trials proposed by statistician Dr. Marvin Zelen. In this design, patients are randomized to either the treatment group of the control group before being consented. Because we know which group a given patient is assigned to, consent can be sought conditionally.

Overview

In this design, those patients receiving standard care need not be consented for pariticipation in the study other than possibly for privacy issues. On the other hand, those patients randomized to the experimental group are consented as usual, except that they are consenting to the certainty of receiving the experimental treatment only; alternatively these patients can decline and receive the standard treatment instead.

In comparison, the current predominant design is for consent to be solicited prior to randomization. That is, eligible patients are asked if they would agree to participate in the clinical trial as a whole. This entails agreeing to receiving the experimental treatment as a possibility, receiving the control treatment as a possibility, and the uncertainty involved in not knowing.

tatistical and epidemiological issues

There are a number of advantages conferred by the pre-randomization consent design.
*Clinicians are more comfortable with this design because each time consent is only sought for one treatment without the uncertainty of randomization.
*Patients correspondingly are not subjected to the uncomfortable feeling that she may or may not be receiving the experimental treatment. This means such effects as resentful demoralization will not become an issue. Analogously, since patients allocated to the standard care group are not necessarily aware of the existence of an alternative treatment, Hawthorne effect is also less of an issue.

Some disadvantages include:
*Contamination by crossing over may be more likely since patients assigned to the treatment group is fully aware of their assignment. We note that the statistical analysis should be performed with intention-to-treat.

Ethical issues

More on ethical issues here.

More on double post-randomized consent design.

ee also

* randomized controlled trial
* statistics

External links